Your browser doesn't support javascript.
loading
Adherence to Oral Treatments in Older Patients with Advanced Prostate Cancer, the ADHERE Study: A Prospective Trial of the Meet-URO Network.
Rescigno, Pasquale; Maruzzo, Marco; Rebuzzi, Sara Elena; Murianni, Veronica; Cinausero, Marika; Lipari, Helga; Fratino, Lucia; Gamba, Teresa; De Giorgi, Ugo; Caffo, Orazio; Bimbatti, Davide; Dri, Arianna; Mosca, Alessandra; Giunta, Emilio Francesco; Ermacora, Paola; Vignani, Francesca; Msaki, Aichi; Bonifacio, Barbara; Lombardo, Valentina; Conteduca, Vincenza; Basso, Umberto; Fornarini, Giuseppe; Banna, Giuseppe Luigi.
Afiliación
  • Rescigno P; Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy.
  • Maruzzo M; Medical Oncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto IOV IRCCS, Padova, Italy.
  • Rebuzzi SE; Medical Oncology Unit, Ospedale San Paolo, Savona, Italy.
  • Murianni V; Department of Internal Medicine and Medical Specialties (Di.M.I.), University of Genova, Genova, Italy.
  • Cinausero M; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Lipari H; Department of Oncology, ASUFC Santa Maria Della Misericordia, Udine, Italy.
  • Fratino L; Division of Medical Oncology, Cannizzaro Hospital, Catania, Italy.
  • Gamba T; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano CRO-IRCCS, Aviano, Italy.
  • De Giorgi U; Medical Oncology, Mauriziano Hospital,Turin, Italy.
  • Caffo O; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
  • Bimbatti D; Department of Medical Oncology, Santa Chiara Hospital, Trento, Italy.
  • Dri A; Medical Oncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto IOV IRCCS, Padova, Italy.
  • Mosca A; Department of Oncology, ASUFC Santa Maria Della Misericordia, Udine, Italy.
  • Giunta EF; Department of Medicine, University of Udine, Udine, Italy.
  • Ermacora P; Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy.
  • Vignani F; Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy.
  • Msaki A; Department of Oncology, ASUFC Santa Maria Della Misericordia, Udine, Italy.
  • Bonifacio B; Medical Oncology, Mauriziano Hospital,Turin, Italy.
  • Lombardo V; Medical Oncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto IOV IRCCS, Padova, Italy.
  • Conteduca V; Department of Oncology, ASUFC Santa Maria Della Misericordia, Udine, Italy.
  • Basso U; Division of Medical Oncology, Cannizzaro Hospital, Catania, Italy.
  • Fornarini G; Department of Medical and Surgical Sciences, Unit of Medical Oncology and Biomolecular Therapy, University of Foggia, Policlinico Riuniti, Foggia, Italy.
  • Banna GL; Medical Oncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto IOV IRCCS, Padova, Italy.
Oncologist ; 27(12): e949-e956, 2022 Dec 09.
Article en En | MEDLINE | ID: mdl-35920559

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Tipo de estudio: Clinical_trials / Observational_studies Límite: Aged / Aged80 / Humans / Male Idioma: En Revista: Oncologist Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Tipo de estudio: Clinical_trials / Observational_studies Límite: Aged / Aged80 / Humans / Male Idioma: En Revista: Oncologist Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Italia